52 studies found for:    Open Studies | "Pruritus"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Pruritus"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Open Label Extension Study of Nalbuphine HCl ER in Hemodialysis Patients With Uremic Pruritus
Conditions: Uremic Pruritus;   Pruritus
Interventions: Drug: nalbuphine HCl ER 60mg BID;   Drug: nalbuphine HCl ER 90mg BID;   Drug: nalbuphine HCl ER 120mg BID
2 Recruiting Effect of Neurokinin-1 Receptor (NK1R) Antagonism on Pruritus in Patients With Sezary Syndrome
Conditions: Sezary Syndrome;   Pruritus
Interventions: Drug: Aprepitant;   Drug: Placebo
3 Recruiting Efficacy of Laser Acupuncture on Pruritus in Patients With Chronic Kidney Disease Undergoing Hemodialysis
Conditions: Pruritus;   Kidney Failure, Chronic
Interventions: Device: Laser acupuncture (Olympic);   Device: Sham Laser acupuncture (Olympic)
4 Unknown  Efficacy of Pregabalin in the Management of Chronic Uremic Pruritus
Condition: Uremic Pruritus
Interventions: Drug: Pregabalin;   Drug: Placebo
5 Not yet recruiting Pregabalin for the Treatment of Uremic Pruritus
Condition: Uremic Pruritus
Interventions: Drug: pregabalin 75mg daily for 12 weeks;   Drug: fexofenadine 60 mg daily for 12 weeks;   Drug: placebo
6 Unknown  Gabapentin - A Solution to Uremic Pruritus?
Conditions: Pruritus;   Uremia
Intervention: Drug: Gabapentin
7 Unknown  A Randomized-Withdrawal Phase 3 Study Evaluating the Safety and Efficacy of Oral Nalfurafine HCl (AC-820)in Subjects on Hemodialysis With Uremic Pruritus (Renal Itch)
Condition: Uremic Pruritus
Interventions: Drug: Nalfurafine HCl 2.5 µg;   Drug: Nalfurafine HCl 5.0 µg;   Other: Placebo
8 Recruiting Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
Conditions: Pruritus;   Atopic Dermatitis
Interventions: Drug: Asimadoline;   Drug: Placebo
9 Not yet recruiting Tradipitant in Treatment-resistant Pruritus Associated With Atopic Dermatitis
Conditions: Atopic Dermatitis;   Eczema;   Chronic Pruritus
Interventions: Drug: Tradipitant;   Drug: Placebo
10 Recruiting A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Skin Pruritus
Condition: Skin Pruritus
Interventions: Drug: PAC-14028 cream 0.1%;   Drug: PAC-14028 cream 0.3%;   Drug: PAC-14028 cream 1.0%;   Drug: PAC-14028 cream vehicle
11 Recruiting Study of Using Long Acting Antihistamine to Treat Opioid Induced Itching
Condition: Pruritus
Interventions: Drug: Cetirizine;   Drug: Placebo or sugar pill
12 Unknown  Treatment of Uremic Pruritus by Olive-omega 3 Ointment
Condition: Uremic Pruritus
Intervention: Procedure: application of ointment (olive-omega 3 ointment)
13 Not yet recruiting Itch Relieving Effect of Botox: a Study in Healthy Subjects
Condition: Pruritus
Interventions: Drug: Botox;   Drug: Saline
14 Unknown  Acticoat Absorbent and BCT Antimicrobial for STSG Donor Site on Thigh
Conditions: Wound Healing;   Wound Infection;   Pain;   Pruritus;   Cicatrix
Interventions: Device: Acticoat Absorbent;   Device: BCT
15 Recruiting Atopic Dermatitis Itch
Condition: Cutaneous Nerves CNS Itch
Interventions: Drug: Clonidine;   Drug: Naltrexone
16 Not yet recruiting A Phase 2 Trial of Neurokinin-1 Receptor Antagonist for the Treatment of Itch in Epidermolysis Bullosa Patients
Conditions: Epidermolysis Bullosa;   Pruritus
Interventions: Drug: VPD-737;   Drug: Placebo
17 Recruiting Effects of Transcranial Direct Current Stimulation (tDCS) on Neuropathic Symptoms Following Burn Injury
Conditions: Burn Injury;   Chronic Pain;   Pruritus;   Itching
Intervention: Device: Transcranial direct current stimulation (tDCS)
18 Recruiting Study of Nalbuphine HCl ER Tablets in Patients With Prurigo Nodularis
Conditions: Prurigo Nodularis;   Nodularis Prurigo;   Prurigo;   Pruritus
Interventions: Drug: nalbuphine HCl ER tablets 90 mg BID;   Drug: nalbuphine HCl ER tablets 180 mg BID;   Drug: Placebo tablets BID
19 Not yet recruiting A Study to Investigate the Receptor Occupancy of SK-1405 in Healthy, Caucasian, Male Subjects
Condition: Pruritus
Intervention: Drug: SK-1405
20 Unknown  Optimal Dose of Prophylactic Naloxone in Reducing Opioid-Induced Side Effects in Children/Adolescents
Conditions: Pain;   Nausea;   Pruritus
Intervention: Drug: naloxone

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years